Cargando…
Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture
BACKGROUND: The liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of liver physiology as well as for the drug development. Hepatocytes are, however, h...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917760/ https://www.ncbi.nlm.nih.gov/pubmed/35279203 http://dx.doi.org/10.1186/s13287-022-02776-5 |
_version_ | 1784668617954033664 |
---|---|
author | Akiyama, Saeko Saku, Noriaki Miyata, Shoko Ite, Kenta Toyoda, Masashi Kimura, Tohru Kuroda, Masahiko Nakazawa, Atsuko Kasahara, Mureo Nonaka, Hidenori Kamiya, Akihide Kiyono, Tohru Kobayshi, Tohru Murakami, Yasufumi Umezawa, Akihiro |
author_facet | Akiyama, Saeko Saku, Noriaki Miyata, Shoko Ite, Kenta Toyoda, Masashi Kimura, Tohru Kuroda, Masahiko Nakazawa, Atsuko Kasahara, Mureo Nonaka, Hidenori Kamiya, Akihide Kiyono, Tohru Kobayshi, Tohru Murakami, Yasufumi Umezawa, Akihiro |
author_sort | Akiyama, Saeko |
collection | PubMed |
description | BACKGROUND: The liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of liver physiology as well as for the drug development. Hepatocytes are, however, hardly expandable in vitro making it difficult to secure large numbers of cells from one donor. Alternatively, systems using animal models and hepatocellular carcinoma cells have been established, but interspecies differences, variation between human cell sources and limited hepatic functions are among the challenges faced when using these models. Therefore, there is still a need for a highly stable method to purify human hepatocytes with functional sufficiency. In this study, we aimed to establish an in vitro long-term culture system that enables stable proliferation and maintenance of human hepatocytes to ensure a constant supply. METHODS: We first established a growth culture system for hepatocytes derived from patients with drug-induced liver injury using fetal mouse fibroblasts and EMUKK-05 medium. We then evaluated the morphology, proliferative capacity, chromosome stability, gene and protein expression profiles, and drug metabolic capacity of hepatocytes in early, middle and late passages with and without puromycin. In addition, hepatic maturation in 3D culture was evaluated from morphological and functional aspects. RESULTS: In our culture system, the stable proliferation of human hepatocytes was achieved by co-culturing with mouse fetal fibroblasts, resulting in dedifferentiation into hepatic progenitor-like cells. We purified human hepatocytes by selection with cytocidal puromycin and cultured them for more than 60 population doublings over a span of more than 350 days. Hepatocytes with high expression of cytochrome P450 genes survived after exposure to cytocidal antibiotics because of enhanced drug-metabolizing activity. CONCLUSIONS: These results show that this simple culture system with usage of the cytocidal antibiotics enables efficient hepatocyte proliferation and is an effective method for generating a stable supply of hepatocytes for drug discovery research at a significant cost reduction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02776-5. |
format | Online Article Text |
id | pubmed-8917760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89177602022-03-21 Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture Akiyama, Saeko Saku, Noriaki Miyata, Shoko Ite, Kenta Toyoda, Masashi Kimura, Tohru Kuroda, Masahiko Nakazawa, Atsuko Kasahara, Mureo Nonaka, Hidenori Kamiya, Akihide Kiyono, Tohru Kobayshi, Tohru Murakami, Yasufumi Umezawa, Akihiro Stem Cell Res Ther Research BACKGROUND: The liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of liver physiology as well as for the drug development. Hepatocytes are, however, hardly expandable in vitro making it difficult to secure large numbers of cells from one donor. Alternatively, systems using animal models and hepatocellular carcinoma cells have been established, but interspecies differences, variation between human cell sources and limited hepatic functions are among the challenges faced when using these models. Therefore, there is still a need for a highly stable method to purify human hepatocytes with functional sufficiency. In this study, we aimed to establish an in vitro long-term culture system that enables stable proliferation and maintenance of human hepatocytes to ensure a constant supply. METHODS: We first established a growth culture system for hepatocytes derived from patients with drug-induced liver injury using fetal mouse fibroblasts and EMUKK-05 medium. We then evaluated the morphology, proliferative capacity, chromosome stability, gene and protein expression profiles, and drug metabolic capacity of hepatocytes in early, middle and late passages with and without puromycin. In addition, hepatic maturation in 3D culture was evaluated from morphological and functional aspects. RESULTS: In our culture system, the stable proliferation of human hepatocytes was achieved by co-culturing with mouse fetal fibroblasts, resulting in dedifferentiation into hepatic progenitor-like cells. We purified human hepatocytes by selection with cytocidal puromycin and cultured them for more than 60 population doublings over a span of more than 350 days. Hepatocytes with high expression of cytochrome P450 genes survived after exposure to cytocidal antibiotics because of enhanced drug-metabolizing activity. CONCLUSIONS: These results show that this simple culture system with usage of the cytocidal antibiotics enables efficient hepatocyte proliferation and is an effective method for generating a stable supply of hepatocytes for drug discovery research at a significant cost reduction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02776-5. BioMed Central 2022-03-12 /pmc/articles/PMC8917760/ /pubmed/35279203 http://dx.doi.org/10.1186/s13287-022-02776-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Akiyama, Saeko Saku, Noriaki Miyata, Shoko Ite, Kenta Toyoda, Masashi Kimura, Tohru Kuroda, Masahiko Nakazawa, Atsuko Kasahara, Mureo Nonaka, Hidenori Kamiya, Akihide Kiyono, Tohru Kobayshi, Tohru Murakami, Yasufumi Umezawa, Akihiro Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture |
title | Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture |
title_full | Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture |
title_fullStr | Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture |
title_full_unstemmed | Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture |
title_short | Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture |
title_sort | drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917760/ https://www.ncbi.nlm.nih.gov/pubmed/35279203 http://dx.doi.org/10.1186/s13287-022-02776-5 |
work_keys_str_mv | AT akiyamasaeko drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT sakunoriaki drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT miyatashoko drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT itekenta drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT toyodamasashi drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT kimuratohru drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT kurodamasahiko drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT nakazawaatsuko drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT kasaharamureo drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT nonakahidenori drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT kamiyaakihide drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT kiyonotohru drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT kobayshitohru drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT murakamiyasufumi drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture AT umezawaakihiro drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture |